Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV

Published:2018-04-24 Issue:1 Volume:7 Page:1-12
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Jiang Yuting¹,Zhao Guangyu¹,Song Nianping¹,Li Pei¹,Chen Yuehong¹,Guo Yan¹,Li Junfeng¹,Du Lanying²,Jiang Shibo²³,Guo Renfeng⁴,Sun Shihui¹,Zhou Yusen¹

Affiliation:

1. State Key Laboratory of Pathogen and BiosecurityBeijing Institute of Microbiology and Epidemiology 100071 Beijing China

2. Lindsley F. Kimball Research InstituteNew York Blood Center 10065 New York NY USA

3. Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical CollegeFudan University 200032 Shanghai China

4. InflaRx GmbH Jena Germany

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

http://www.nature.com/articles/s41426-018-0063-8.pdf

Reference45 articles.

1. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

2. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome

3. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

4. Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description

5. Middle East Respiratory Syndrome Coronavirus Disease in Children

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The complement cascade in lung injury and disease;Respiratory Research;2024-01-04

2. Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial;The Lancet Respiratory Medicine;2023-12

3. Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial;The Lancet Respiratory Medicine;2023-12

4. C5a drives the inflammatory response with bacterial dose effect by binding to C5aR1 in zebrafish infected with Aeromonas hydrophila;Fish & Shellfish Immunology;2023-08

5. Thromboembolism: the secret lethal weapon of coronavirus disease 2019;REV RES MED MICROBIO;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3